We’re buying more of this life sciences stock after an earnings-driven decline
[ad_1] The stock is under pressure in early trading due to uncertainty around the recovery in a key business. [ad_2] Source link
Veralto Corp
Read More
Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition
[ad_1] Jim Cramer ran through the names during the Club’s October Monthly Meeting on Wednesday. [ad_2] Source link
It’s time to get bullish on this health tech name, now that it’s shed a drag on growth
[ad_1] We care much more about where a stock is going than where it’s been. With the spin-off of Veralto (VLTO) complete, we decided to look at the path ahead for Danaher (DHR) — now free of its slower-growing, lower-margin water business. In the separation , we decided to keep the 173 shares of Veralto…
We’re set to receive shares in Danaher’s separated water business. Here’s our plan for the new stock
[ad_1] Danaher (DHR) is a day away from shedding its environmental-and-applied solutions segment, and the Club holding’s ability to deliver returns for shareholders appears stronger than ever. Those potential returns can come from two places: Danaher stock and shares of Veralto (VLTO), the soon-to-be-standalone company that’s in the business of water quality. We see underappreciated…